You are here

Blockbuster cancer treatments give US drugmakers a boost

New York

US drugmakers got a strong start to the year with help from the newest cancer medications, which take advantage of cutting-edge research and have the price tags to prove it.

Pfizer Inc, Merck & Co and Bristol-Myers Squibb Co all beat Wall Street's earnings projections